GlobeNewswire Inc | Jan 14, 2021 09:49AM EST

January 14, 2021

MONTREAL, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Paul Levesque, President and Chief Executive Officer and Dr. Christian Marsolais, Senior Vice President and Chief Medical Officer will present at the B. Riley Virtual Oncology Investor Conference on Wednesday, January 20, 2021 at 3:30 p.m. ET.

To access the live virtual presentation, please visit the News section of the Companys website. A webcast replay will also be available approximately two hours after the presentation.

About Theratechnologies Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov.

For media inquiries:Denis BoucherVice-President, Communications and Corporate Affairs514-336-7800

For investor inquiries:Leah GibsonSenior Director, Investor Relationslgibson@theratech.com617-356-1009